3Detry JM, Sellier P, Pennaforte S, et al. Trimetazidine: a new concept in the treatment of angina: comparison witht propranolol in patients with stable angina. Trimetazidine European Multicenter study Group. Br J Clin Pharmacol, 1994,3:279 ～ 288
4Kantor PF, Lucien A, Kozak R, et al.The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long - chain 3- ketoacyl coenzyme A thiolase. Circ Res, 2000, 86(5) :580 ～ 588
5Mody FV, Singh BN, Moihuddin IH,et al. Trimetazidine - induced enhancement of myocardial glucose utilization in normal and ischemic myocardial tissue: an evaluation by positron emission tomography. Am J Cardiol, 1998, 82:42K～49K
6Lopaschuk GD, Kozak R. Trimetazidine inhibits fatty acid oxidation in the heart. J Mol Cell Cardiol, 1998, 30:A122
7Opie LH, Boucher F. Trimetazidine and myocardial ischemic contracture in isolated rat heart. Am J Cardiol,1995, 75:38B ～ 40B
8[1]Opie LH. Proof that glucose-insulin potassium provides metabolic protection of ischemia myocardium [J]. Lancet, 1999, 353: 768.
9[2]Hanchanda SC, Krishnaswami S. Combination treatment with trimetazidine and diltiazem in stable angina pectoris [J]. Heart,1997, 78: 353-357.
10[3]Detry JM, Leclercq PJ. Trimetazidine European multicenter study versus propranolol in stable angina pectoris :contribution of Holter electrocardiographic ambulatory mornitoring [J]. Am J Cardiol,1995, 76: 8-11.
